Skip to content

The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain

DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02666456
Enrollment
1500
Registered
2016-01-28
Start date
2016-04-30
Completion date
Unknown
Last updated
2016-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain, Peripheral Nerve Injury, Polyneuropathy

Brief summary

Cross-sectional and longitudinal analysis of the somatosensory phenotype, assessed by quantitative sensory testing (QST) and Information obtained by questionnaires to detect risk factors for neuropathic pain development and chronification in painless and chronic pain patients.

Interventions

OTHERQST, Questionnaires

Assessment of sensory phenotype by QST and questionnaires

Sponsors

University of Kiel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic peripheral neuropathic pain or * Painless Patient with risk to develop neuropathic pain (post-surgery, chemotherapy-induced)

Exclusion criteria

* Minors

Design outcomes

Primary

MeasureTime frameDescription
Somatosensory phenotype detected by quantitative sensory testing (QST)Single assessment at baseline (cross-sectional study). Report of complete cohort data at study completionThe somatosensory phenotype will be assessed by quantitative sensory testing (QST) once at baseline
Change of neuropathic pain: Development and chronification of neuropathic pain detected by DN4 questionnaireAssessment of change of neuropathic pain from baseline and 6 months after study enrollment (longitudinal study). Report of complete cohort data at study completion.Assessment with DN4 pain questionnaire

Contacts

Primary ContactAndreas Binder, MD
andreas.binder@uksh.de+49 431 597

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026